Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $6.7700 (-1.67%) ($6.7700 - $6.7700) on Mon. Nov. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.97% (three month average) | RSI | 68 | Latest Price | $6.7700(-1.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.7% a day on average for past five trading days. | Weekly Trend | AUTL advances 10% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(53%) IBUY(50%) ARKG(49%) ARKK(49%) BLOK(49%) | Factors Impacting AUTL price | AUTL will decline at least -2.485% in a week (0% probabilities). VIXM(-34%) VXX(-30%) TLT(-23%) SHY(-23%) BNDX(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.485% (StdDev 4.97%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.76(0.15%) | 10 Day Moving Average | $6.38(6.11%) | 20 Day Moving Average | $6.05(11.9%) | To recent high | -8.1% | To recent low | 25.1% | Market Cap | $354m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |